Reports &amp; White Papers

Science 37 Solutions Fact Sheet

Science 37 offers a comprehensive suite of solutions that are transforming the landscape of clinical research, providing unprecedented access, efficiency, and patient-centricity.…

/Resources/science-37-solutions-fact-sheet

Science 37 Patient Recruitment

Central patient recruitment campaigns have proven helpful in accelerating enrollment, but the overwhelming majority of participant referrals never make it to the first office visit…

/Resources/science-37-patient-recruitment

How to Operationalize Neurology Clinical Trials with the Metasite™

With a virtual site, clinical trial sponsors and research organizations can expand access and accelerate recruitment by allowing patients to participate from anywhere, regardless of…

/Resources/how-operationalize-neurology-clinical-trials-metasitetm

How to Operationalize Respiratory Clinical Trials with the Metasite™

Are you looking to expand patient access for your respiratory clinical trials? Discover how a virtual site solution allows patients to enroll and participate in trials from anywhere,…

/Resources/how-operationalize-respiratory-clinical-trials-metasitetm

A Survey-Based Exploration of Biopharma's Shifting Landscape and the Crucial Role of Direct-to-Patient Trials

In the ever-changing landscape of clinical research, transformation is driven by forces of economic challenges, increasingly slender budgets, and the persistent hurdle of patient…

/Resources/survey-based-exploration-biopharmas-shifting-landscape-and-crucial-role-direct-patient

How to Operationalize Cardiology Clinical Trials with a Metasite™

Virtual sites (like the Science 37 Metasite™) are a patient-friendly decentralized clinical trial (DCT) model that enables expansive trial access and can support a…

/Resources/how-operationalize-cardiology-clinical-trials-metasitetm

eCOA Systems and Intended Use: Key Considerations

Science 37 VP of Global Product Development, Lisa Charlton, and other experts from the Critical Path Institute Consortium provided important considerations when interpreting data…

https://www.appliedclinicaltrialsonline.com/view/ecoa-systems-and-intended-use-key-considerations

More than Just Rules: Raising the Bar in GCP Adherence

Science 37 Chief Medical Officer, Dr. Jonathan Cotilar, spoke with Applied Clinical Trials about training operations at Science 37, sharing how training happens regularly at various…

https://www.appliedclinicaltrialsonline.com/view/more-than-just-rules-raising-the-bar-in-gcp-adherence

How to Operationalize Psychiatry Trials with the Science 37 Metasite™

Driven by the Metasite, Science 37 is at the forefront of delivering accessible and patient-friendly decentralized clinical trials (DCT) and is leading the delivery of standard…

/Resources/how-operationalize-psychiatry-trials-science-37-metasitetm

Science 37 Receives the 2023 Frost & Sullivan Market Leadership Award

Science 37 has been recognized with the prestigious Frost & Sullivan Market Leadership Award in the global decentralized clinical trials (DCT) industry. This acknowledgment…

/market-leader-award

FDA’s Landmark Guidance on Decentralized Clinical Trials (DCTs) Signals a New Era of Patient-Centered Research

In this paper, published in MedCity News, Science 37 Chief Medical Officer Dr. Jonathan Cotliar explores the FDA Draft Guidance on decentralized clinical trials (DCTs). With…

https://medcitynews.com/2023/05/fdas-landmark-guidance-on-decentralized-clinical-trials-dcts-signals-a-new-era-of-patient-centered-research/

New FDA Draft Guidance Shows That the Time for Decentralized Clinical Trials is Now

On May 1, 2023, the U.S. Food and Drug Administration (FDA) released an updated Draft Guidance on decentralized trials, providing recommendations for clinical trial sponsors as they…

/Resources/new-fda-draft-guidance-shows-time-decentralized-clinical-trials-now

Transform Real-World Evidence (RWE) Studies with Virtual Approaches

Transform RWE Studies with Virtual Approaches

Increased adoption of mobile devices, wearables, and other biosensor technologies has created a wealth of real-world data (RWD) sources for clinical trial sponsors to leverage for both…

/Resources/transform-rwe-studies-virtual-approaches

Transform Observational Studies with a Virtual Site

Are your observational or long-term follow-up studies facing challenges? Are keeping protocols open across multiple sites slowing down your studies? Or is loss of participant…

/Resources/transform-observational-studies-virtual-site

How Science 37 Partners with Contract Research Organizations

As the pioneer in virtual clinical trials, Science 37 offers contract research organizations (CROs) the most experience and ability to accelerate study timelines. Through in-…

/Resources/how-science-37-partners-contract-research-organizations

How to Operationalize Dermatology Clinical Trials with a Virtual Site

Clinical trials for dermatology can be a uniquely challenging endeavor for sponsors and clinical researchers, as it is challenging to identify and support patients who have not…

/Resources/how-operationalize-dermatology-clinical-trials-virtual-site

Science 37's mission is to accelerate clinical research by enabling universal trial access for patients. As a single Metasite, we reach an expanded patient population beyond the…

The Science 37 Metasite™

/Resources/science-37-metasitetm

How to Save an At-Risk Clinical Trial

How can you rescue an at-risk clinical trial without compromising quality? Delays in clinical research are common and cost pharmaceutical companies exorbitant amounts of money. Four in…

/Resources/how-save-risk-clinical-trial

How to Operationalize Infectious Disease Trials with a Virtual Site

Download our Infectious Disease Clinical Trial Playbook to discover the premier, patient-centric strategy for solving hallmark challenges in infectious disease research. In this…

Clinical Decision Makers Confirm a Shift to Hybrid and Decentralized Studies

/Resources/how-operationalize-infectious-disease-trials-virtual-site

Infographic

Clinical research is undergoing transformation across the board—but how will it impact oncology clinical trials? Science 37® has surveyed research executives at trial-sponsored…

Science37_OncologySurvey_Infographic_112822.pdf

/Resources/clinical-decision-makers-confirm-shift-hybrid-and-decentralized-studies

How to Operationalize Oncology Trials with a Decentralized Approach

The importance of oncology in pharmaceutical research cannot be underestimated. However, oncology trials face challenges such as slow recruitment, complex protocols and frequent…

/Resources/how-operationalize-oncology-trials-decentralized-approach

Decentralized Clinical Trials — Is There a Positive Return on Investment on a Virtual Site?

Across the Life Sciences industry, there has been much talk about the cost and value of decentralized clinical trials (DCT) and the potential return on investment (ROI) when the…

Calculate your Virtual Site ROI with a Science 37 Expert

/Resources/Modeling-Trial-Cost-and-Timelines-to-Maximize-Decentralized-Clinical-Trial-ROI

ROI Calculator

Schedule time with a Science 37 expert and receive personalized results on how decentralized solutions can: Accelerate timelines Save opportunity costs Increase patient enrollment…

/Resources/calculate-your-trial-savings-science-37-expert

Evaluating the Use of Backup Solutions for ePRO Systems

A retrospective examination of the effectiveness, usability, and challenges with web-based electronic clinical outcome assessment (eCOA) backups.

https://www.appliedclinicaltrialsonline.com/view/evaluating-the-use-of-backup-solutions-for-epro-systems

How Decentralized and Hybrid Trials are Impacting Clinical Research

Patient accessing teleheatlh in a decentralized clinical trial

Science 37’s 2nd Annual The Future of Clinical Trials Survey shares how the acceleration and adoption of decentralized clinical trials will reshape the research landscape in 2023.…

/decentralized-clinical-trials-trends-report-2022

How to Meet the FDA Diversity Action Plan Guidance

The pending FDA Guideline’s intention is clear—pharma companies must plan, report and collaborate to improve diverse representation in clinical trials. Most sponsors have assessed…

S37_WhitePaper_Diversity_July2022_final2 (1).pdf

/Resources/how-meet-fda-diversity-action-plan-guidance

Why Migraine and Other Headache Disorders Are a Good Fit for Decentralized Clinical Trials

Patient accessing decentralized clinical trials

Characterized by recurring episodes of moderate to severe headache, elevated sensitivity to sound and/or light and other unpleasant symptoms, migraines can often be debilitating for…

Migraine Insight Brief (1).pdf

/Resources/why-migraine-headache-disorders-are-good-fit-decentralized-clinical-trials

Decentralized Clinical Trials in Oncology: Are We Ready for a Virtual-First Paradigm?

In this paper, published in the Journal of Clinical Oncology, Dr. Shaalan Beg MD MS and team explore how decentralized clinical trial tools are poised to impact the oncology…

https://ascopubs.org/doi/full/10.1200/JCO.22.00358

An Executive Clinical Trial Playbook

How Decentralized and Hybrid Clinical Trials Accelerate Research and Enable Diversity While no longer a new concept, decentralized clinical trials can be challenging to…

/clinicaltrialplaybook

Decentralized Clinical Trial Technology— How to Accelerate eCOA Implementation

The key benefits of decentralized clinical trials is the ability to enable faster implementation of trials, greater speed to go live, and accelerated timelines. Electronic…

S37_InsightBrief_eCOA_July2022_r3.pdf

/Resources/decentralized-clinical-trial-technology-how-accelerate-ecoa-implementation

How Decentralized Clinical Trials are Impacting Oncology Research

Clinical research is undergoing transformation across the board—but how will it impact oncology clinical trials? Science 37® has surveyed research executives at trial-sponsored…

S37_ONC_FullReport_R8.pdf

/Resources/how-decentralized-clinical-trials-are-impacting-oncology-research

Improve Long-Term Follow-Up Studies with Decentralized Clinical Trials

Improve Long-Term Follow-Up Studies with DCT

In his latest insight brief, Gordon Cummins shares how more agile and DCT approaches can optimize the delivery of long-term follow-up studies—improving and accelerating Real World…

RWE_InsightBrief_d05.pdf

/Resources/improve-long-term-follow-studies-dct

Accelerate Enrollment and Enable Diversity with The Science 37 Metasite™

Traditional clinical trials exclude more than 90 percent of patients and providers because of geographic and access barriers. This leads to study delays, excessive costs, and…

S37_FactSheet_Metasite_Apr2022_r6.pdf

/Resources/accelerate-enrollment-and-enable-diversity-science-37-metasitetm

Mobile Nursing: A Global Mobile Healthcare Network

Mobile Nursing: A Global Mobile Healthcare Provider Network

The healthcare landscape has changed, and mobile healthcare is now an integral part of clinical research. Beyond nursing, mobile healthcare must deliver more – compassion,…

Mobile Nursing Fact Sheet - March 2022.pdf

/Resources/mobile-nursing-global-mobile-healthcare-network

Decentralization: An Ethical Obligation

We have the capability to reach anyone, anywhere utilizing decentralized clinical trial techniques and more agile clinical trial designs.

For more than 60 years, the traditional clinical trial model has relied on a disparate network of independent investigator sites to find, enroll, and matriculate patients through a…

S37_InsightBrief_DecentralizationAnEthicalObligation_r3.pdf

/sites/default/files/2022-04/S37_InsightBrief_DecentralizationAnEthicalObligation_r3.pdf

Powering Rare Disease Research with Agile, Decentralized and Patient- Centric Approaches

Clinical trials for rare diseases have always presented challenges. From investigator training to data collection, conducting clinical research for orphan disorders is mired with condition-specific challenges that slow development and place an enormous burden on patients wanting to participate in a potentially life-saving clinical trial.

Through the rapidly increasing trend of agile, patient-centric approaches, we can address the distinctive challenges for patients with rare diseases. Travel may be difficult. Many are…

Rare_Disease_Webinar_Insight_Brief_Web.pdf

/Resources/powering-rare-disease-research-agile-decentralized-and-patient-centric-approaches-0

Making Rare Disease Research Easier for Patients, Easier for Everyone

Through the rapidly increasing trend of patient-centric research, we can address the distinctive challenges for patients with rare diseases. Travel may be difficult. Many are…

Rare_Disease_Fact_Sheet_Web.pdf

/Resources/making-rare-disease-research-easier-patients-easier-everyone

How Agile Clinical Trials are Impacting CNS Research

How will decentralization impact CNS (central nervous system) clinical trials? Science 37 has surveyed research executives at trial-sponsoring organizations, uncovering pivotal insights on how clinical research trends are impacting the CNS space.

We know that clinical research is undergoing transformation across the board—but how will it impact CNS (central nervous system) clinical trials? Science 37® has surveyed research…

S37_CNS_FullReport_R9.pdf

/Resources/how-agile-clinical-trials-are-impacting-cns-research

Centralize Clinical Trials with Decentralized Clinical Trials

As the industry adopts more agile and decentralized approaches, it has rallied around the term decentralized clinical trials and expanded its definition to include all mobile, remote,…

Insight Brief Centralize Clinical Trials.pdf

/sites/default/files/2022-05/Decentralized_Clinical_Trials_Insight_Brief_d01.pdf

The Decentralized Clinical Trial Operating System

A requisite, technology-first platform with limitless configurations to enable clinical research.

/DCT-OS-Report

Clinical Research in the COVID-19 Era: Methods for Continuity

Adjust ongoing trials and have the changes expeditiously reviewed by an accredited IRB.

/Covid-19

Empowering Diversity in Clinical Trials

Diverse audiences want to participate in clinical trials but so often, are not asked, overlooked, or unable to access because of geographic barriers. The Diversity in Clinical…

FACT-SHEET_Science-37-Diversity-and-Inclusion.pdf

/Resources/empowering-diversity-clinical-trials

Navigating Clinical Trials in the Coronavirus Era

Explore approaches to mitigate risks to patient safety in ongoing clinical trials.